(Q35040750)

6 August 2017

1 reference

title

Inhaled corticosteroids plus long-acting beta2-agonists as a combined therapy in asthma (English)

1 reference

6 August 2017

1 reference

Luis García-Marcos

1

1 reference

6 August 2017

Antje Schuster

series ordinal

2

1 reference

6 August 2017

Nicolás Cobos Barroso

series ordinal

3

1 reference

6 August 2017

language of work or name

English

0 references

publication date

1 January 2003

1 reference

Expert Opinion on Pharmacotherapy

6 August 2017

published in

1 reference

6 August 2017

volume

4

1 reference

6 August 2017

issue

1

1 reference

6 August 2017

page(s)

23-39

1 reference

Effects of inhaled glucocorticoids on bone density in premenopausal women

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.1.23

A meta-analysis of the effect of oral and inhaled corticosteroids on growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.1.23

Comparison of the effects of salmeterol and formoterol in patients with severe asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.1.23

Onset of bronchodilation of budesonide/formoterol vs. salmeterol/fluticasone in single inhalers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.1.23

Cost-effectiveness analysis of formoterol versus salmeterol in patients with asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.1.23

Tolerance to the bronchoprotective effect of salmeterol in adolescents with exercise-induced asthma using concurrent inhaled glucocorticoid treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.1.23

Systemic effects of formoterol and salmeterol: a dose-response comparison in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.1.23

Meta-analysis of increased dose of inhaled steroid or addition of salmeterol in symptomatic asthma (MIASMA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.1.23

Addition of salmeterol to low-dose fluticasone versus higher-dose fluticasone: an analysis of asthma exacerbations

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.1.23

Salmeterol added to inhaled corticosteroid therapy is superior to doubling the dose of inhaled corticosteroids: a randomized clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.1.23

Fluticasone alone or in combination with salmeterol vs triamcinolone in asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.1.23

Addition of salmeterol versus doubling the dose of fluticasone propionate in patients with mild to moderate asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.1.23

Step-down therapy with low-dose fluticasone-salmeterol combination or medium-dose hydrofluoroalkane 134a-beclomethasone alone

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.1.23

Fluticasone propionate/salmeterol combination compared with montelukast for the treatment of persistent asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.1.23

Clinical equivalence of salmeterol/fluticasone propionate in combination (50/100 microg twice daily) when administered via a chlorofluorocarbon-free metered dose inhaler or dry powder inhaler to patients with mild-to-moderate asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.1.23

Comparison of inhaled salmeterol and oral zafirlukast in patients with asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.1.23

Comparison of second controller medications in addition to inhaled corticosteroid in patients with moderate asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.1.23

Montelukast or salmeterol combined with an inhaled steroid in adult asthma: design and rationale of a randomized, double-blind comparative study (the IMPACT Investigation of Montelukast as a Partner Agent for Complementary Therapy-trial).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.1.23

Evaluation of salmeterol or montelukast as second-line therapy for asthma not controlled with inhaled corticosteroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.1.23

Salmeterol powder provides significantly better benefit than montelukast in asthmatic patients receiving concomitant inhaled corticosteroid therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.1.23

Inhaled corticosteroids plus salmeterol or montelukast: effects on resource utilization and costs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.1.23

Comparison of the anti-inflammatory properties of formoterol, salbutamol and salmeterol in guinea-pig skin and lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.1.23

Comparison of anti-inflammatory and clinical effects of beclomethasone dipropionate and salmeterol in moderate asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.1.23

Anti-inflammatory effects of salmeterol compared with beclomethasone in eosinophilic mild exacerbations of asthma: a randomized, placebo controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.1.23

Additive anti-inflammatory effect of formoterol and budesonide on human lung fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.1.23

Response of preschool children with asthma symptoms to fluticasone propionate

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.1.23

Cost-effectiveness of fluticasone propionate administered via metered-dose inhaler plus babyhaler spacer in the treatment of asthma in preschool-aged children

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.1.23

Randomized controlled trial of fluticasone in preschool children with intermittent wheeze

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.1.23

Analysis of induced sputum in adults with asthma: identification of subgroup with isolated sputum neutrophilia and poor response to inhaled corticosteroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.1.23

Non-eosinophilic asthma: importance and possible mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.1.23

Inhaled dry-powder formoterol and salmeterol in asthmatic patients: onset of action, duration of effect and potency

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.4.1.23

21 January 2018

Identifiers

DOI

10.1517/14656566.4.1.23

1 reference

6 August 2017

1 reference